Unlocking the Potential of C4orf47 as a Drug Target and Biomarker

Target Name: C4orf47

NCBI ID: G441054

C4orf47

Unlocking the Potential of C4orf47 as a Drug Target and Biomarker

Introduction

Chromosome 4 open reading frame (C4orf47) is a non-coding RNA molecule located within the intron of Chromosome 4 (4p) in humans. It plays a crucial role in the regulation of gene expression and has been implicated in various physiological processes, including cell growth, differentiation, and disease.

C4orf47 is a unique RNA molecule as it has a higher stability than other non-coding RNAs and is expressed in a tissue-specific manner. Its expression patterns have been observed in various tissues, including brain, heart, and muscle, and its levels vary depending on the developmental stage of the organism.

Recent studies have identified potential drug targets and biomarkers associated with C4orf47. In this article, we will explore the potential of C4orf47 as a drug target and biomarker, and discuss the current research on this topic in depth.

C4orf47 as a Drug Target

C4orf47 has been identified as a potential drug target due to its unique structure and various biochemical properties. One of the key factors that make C4orf47 an attractive drug target is its high stability. Unlike other non-coding RNAs, C4orf47 is highly resistant to degradation and has been shown to maintain its stability even in the presence of various cellular stressors, such as temperature and pH changes.

Additionally, C4orf47 has been shown to play a role in the regulation of cellular processes that are crucial for human health, such as cell growth, apoptosis, and inflammation. Its expression has been linked to various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

C4orf47 has also been shown to interact with various protein molecules, including tyrosine kinases, which are known to play a role in the regulation of cellular processes that are crucial for human health. This interaction between C4orf47 and tyrosine kinases makes it an attractive target for small molecules, which can modulate its expression and activity.

C4orf47 as a Biomarker

C4orf47 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its expression has been shown to be elevated in various diseases and has been used as a diagnostic marker in these conditions.

One of the key advantages of C4orf47 as a biomarker is its potential to be used in non-invasive diagnostic tests. Its stability and resistance to degradation make it an ideal candidate for use in fluid-based biopsy and other non-invasive diagnostic tests. in technology.

C4orf47 has also been shown to be involved in the regulation of cellular processes that are crucial for human health, such as cell growth, apoptosis, and inflammation. Its expression has been linked to various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Therefore, its levels can be used as a biomarker to indicate the presence of these diseases.

Conclusion

C4orf47 is a non-coding RNA molecule that has been shown to play a crucial role in the regulation of gene expression and has potential as a drug target and biomarker. Its stability and resistance to degradation, as well as its interaction with protein molecules, make it an attractive target for small molecules. Its expression patterns have been observed in various tissues and its levels vary depending on the developmental stage of the organism. Further research is needed to fully understand the potential of C4orf47 as a drug target and biomarker.

Protein Name: Chromosome 4 Open Reading Frame 47

The "C4orf47 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C4orf47 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets